Singapore - English - HSA (Health Sciences Authority)

roche singapore pte. ltd. - pertuzumab - infusion, solution concentrate - 30 mg/ml - pertuzumab 30 mg/ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

roche products ltd - pertuzumab - solution for infusion - 30mg/1ml

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

roche diagnostics gmbh - pertuzumab - concentrate for solution for infusion - 30mg/ml

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

f. hoffmann-la roche ltd. - pertuzumab - concentrate for solution for infusion - 30mg/ml

European Union - English - EMA (European Medicines Agency)

roche registration gmbh  - pertuzumab - breast neoplasms - antineoplastic agents, monoclonal antibodies - metastatic breast cancer:perjeta is indicated for use in combination with trastuzumab and docetaxel in adult patients with her2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-her2 therapy or chemotherapy for their metastatic disease.neoadjuvant treatment of breast cancer:perjeta is indicated for use in combination with trastuzumab and chemotherapy for the neoadjuvant treatment of adult patients with her2-positive, locally advanced, inflammatory, or early stage breast cancer at high risk of recurrence.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

roche, switzerland - pertuzumab - concentrate for solution for infusion - 420 mg

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية شاوي و رشيدات و مسنات - shawi & rushedat drug store - pertuzumab 420 mg/14ml - 420 mg/14ml

Kenya - English - Pharmacy and Poisons Board

f. hoffman-la roche ltd, basel grenzacherstrasse 124 ch-4070 basel, switzerland - pertuzumab - concentrate for solution for infusion - one 14 ml vial of concentrate contains 420 mg of… - pertuzumab

New Zealand - English - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - pertuzumab 420mg equivalent to 30 mg/ml - concentrate for infusion - 420 mg/14ml - active: pertuzumab 420mg equivalent to 30 mg/ml excipient: glacial acetic acid histidine polysorbate 20 sucrose water for injection - metastatic breast cancer perjeta is indicated in combination with trastuzumab and docetaxel for patients with her2-positive metastatic breast cancer who have not received prior anti-her2 therapy or chemotherapy for their metastatic disease.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

roche diagnostics gmbh - pertuzumab - concentrate for solution for infusion - 30mg/ml